药物受理最新动态：Pfizer Inc.PF-07275315注射液进口申请获受理

Core Viewpoint - Pfizer Inc. has had its application for PF-07275315 injection accepted by the National Medical Products Administration, indicating progress in its drug development pipeline [1] Group 1: Company Information - Pfizer Inc. was established on October 7, 1989, and is classified as a medium-sized foreign-owned limited liability company in the chemical pharmaceutical manufacturing industry [1] - The registered capital of Pfizer Inc. is 8.04 million USD, with the same amount being the paid-in capital [1] - The company has 935 insured employees and is located at 22 Daqing Road, Dalian Economic and Technological Development Zone, Liaoning Province, China [1] Group 2: Application Details - The application for PF-07275315 injection was accepted on December 16, 2025, with the acceptance number JXSL2500239 [1] - PF-07275315 is categorized as a therapeutic biological product and is classified under import registration category 1 [1] - The application is being handled by Pfizer Inc. and Pfizer (China) Research & Development Co., Ltd. [1] Group 3: Shareholder Information - The sole shareholder of Pfizer Inc. is American Huizhi Enterprise Company, holding 100% of the shares with a subscribed capital of 8.04 million USD [1] - The subscribed capital was contributed on November 30, 2017, and the first shareholding date was June 9, 2023 [1]